Back
Grace Therapeutics Stock Price Chart

Mode Mobile Could be Next in Line"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
19
GRCE
Grace Therapeutics
Last Price:
$1.93
Seasonality Move:
5.78%
7 Day Trial
ALL ACCESS PASS
$
7

Shocking Video Could Open Weekend Income Doors.
Go Here Now to Watch it-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GRCE is experiencing slight buying pressure.
Grace Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2 | Sell |
20-day SMA: | 2.25 | Sell |
50-day SMA: | 2.73 | Sell |
200-day SMA: | 3.04 | Sell |
8-day EMA: | 2.02 | Sell |
20-day EMA: | 2.22 | Sell |
50-day EMA: | 2.63 | Sell |
200-day EMA: | 3 | Sell |
Grace Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.23 | Sell |
Relative Strength Index (14 RSI): | 36.44 | Sell |
Chaikin Money Flow: | 9047 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.03 - 2.49) | Sell |
Bollinger Bands (100): | (2.56 - 3.88) | Sell |
Grace Therapeutics Technical Analysis
Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Grace Therapeutics Stock
Is Grace Therapeutics Stock a Buy?
-
Grace Therapeutics share price is 1.98 while GRCE 8-day simple moving average is 2.00, which is a Sell signal.
-
The stock price of GRCE is 1.98 while Grace Therapeutics 20-day SMA is 2.25, which makes it a Sell.
-
Grace Therapeutics 50-day simple moving average is 2.73 while GRCE share price is 1.98, making it a Sell technically.
-
GRCE stock price is 1.98 and Grace Therapeutics 200-day simple moving average is 3.04, creating a Sell signal.
GRCE Technical Analysis vs Fundamental Analysis
Sell
19
Grace Therapeutics (GRCE)
is a Sell
Is Grace Therapeutics a Buy or a Sell?
-
Grace Therapeutics stock is rated a SellThe current Grace Therapeutics [GRCE] share price is $1.98. The Score for GRCE is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
Grace Therapeutics Stock Info
Market Cap:
27.2M
Price in USD:
1.98
Share Volume:
37.1K
Grace Therapeutics 52-Week Range
52-Week High:
4.97
52-Week Low:
1.75
Sell
19
Grace Therapeutics (GRCE)
is a Sell
Grace Therapeutics Share Price Forecast
-
What is the Grace Therapeutics stock price today?The Grace Therapeutics stock price is 1.98 USD today.
-
Will GRCE stock go up or go down?Grace Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Grace Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Grace Therapeutics is overvalued.
Is Grace Therapeutics Stock a Buy?
-
Grace Therapeutics share price is 1.98 while GRCE 8-day exponential moving average is 2.02, which is a Sell signal.
-
The stock price of GRCE is 1.98 while Grace Therapeutics 20-day EMA is 2.22, which makes it a Sell.
-
Grace Therapeutics 50-day exponential moving average is 2.63 while GRCE share price is 1.98, making it a Sell technically.
-
GRCE stock price is 1.98 and Grace Therapeutics 200-day simple moving average is 3.00, creating a Sell signal.
Fundamental Analysis of Grace Therapeutics
Is Grace Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.07 per share, an increase this year of $0.22 per share, and an increase next year of $0.38 per share.
Technical Analysis of Grace Therapeutics
Should I short Grace Therapeutics stock?
-
GRCE Moving Average Covergence Divergence (MACD) indicator is -0.23, suggesting Grace Therapeutics is a Sell
-
Grace Therapeutics Relative Strength Index (RSI) is 36.44, which suggest Grace Therapeutics is oversold
-
The Bollinger Bands (25) for Grace Therapeutics is (2.03 - 2.49), which suggest Grace Therapeutics is a Sell
-
The Bollinger Bands (100) for Grace Therapeutics is (2.56 - 3.88), which suggest Grace Therapeutics is a Sell
* Grace Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.